Contents of anti-Helicobacter pylori antibodies in digestive system diseases
Tsaregorodtseva, T.M.; Serova, T.I.; Gladilina, M.V.; Gubina, A.V.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
2006
ISSN/ISBN: 1682-8658 PMID: 16866247 Document Number: 605034
Document emailed within 1 workday
Related Documents
Tsaregorodtseva, T.M.; Serova, T.N.; Klishina, M.v.; Trubitsina, I.E.; Sokolova, G.N.; Rogozina, V.A.; Chikunova, B.Z.; Zhivaeva, N.S.; Gubina, A.V. 2005: Diagnostic and prognostic value of anti-Helicobacter pylori antibodies at diseases of the digestive apparatus Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 18-21Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Caccavo, D.; Leri, O.; Ferri, G.M.; Perinelli, P.; De Luca, D.; Afeltra, A. 1997: Anti-TNF-alpha antibodies are not associated with Helicobacter pylori induced gastritis European Review for Medical and Pharmacological Sciences 1(4): 111-113
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Fradkin, A.; Yahav, Y.; Diver-Haber, A.; Weisselberg, B.; Jonas, A. 1997: The value of anti-Helicobacter pylori IgG antibodies in establishing eradication of infection in children Israel Journal of Medical Sciences 33(2): 87-92
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Baryshnikova, N.V.; Suvorov, A.N.; Tkachenko, E.I.; Uspenskiĭ, I.P. 2008: Role of genetic features of Helicobacter pylori in pathogenesis of digestive tract diseases: from the theory to practice Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 52-59
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Moayyedi, P.; Tompkins, D.S.; Axon, A.T. 1994: Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy Lancet 344(8928): 1016-1017
Royo, G.; Férez, A.; Esteban, A.; Martín, C.; Pérez-Mateo, M. 1991: Antibodies against Helicobacter pylori in gastroenterology personnel, patients and the healthy population Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 80(4): 233-236
Meyer, O.; Abuaf, N.; Cyna, L.; Homberg, J.C.; Kahn, M.F.; Ryckewaert, A. 1987: Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases Clinical and Experimental Immunology 69(3): 485-492
Barbosa, J.; Dinis-Ribeiro, M.; Guilherme, M.; Filipe, T.; Lomba-Viana, R.; Guimarães, M.A.; Lopes, C. 2003: Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia British Journal of Biomedical Science 60(4): 175-179
Zaterka, S. 2001: Anti-secretory agents modify the gastric localization of Helicobacter pylori Arquivos de Gastroenterologia 38(1): 1-2
Xie, Y.; Zhou, N.-j.; Xiong, S.-y.; Chen, J.; Gong, Y.-f.; Lü, N.-h.; Wang, C.-w. 2007: Anti-Helicobacter pylori effect and regulation of T helper response of chitosan Zhonghua Nei Ke Za Zhi 46(3): 220-223
Sugiyama, T.; Yoshioka, M.; Furuta, Y.; Miyasaka, K. 2004: What is Helicobacter pylori?: associated diseases in human Hokkaido Journal of Medical Science 79(2): 111-115
Garza Yado, Mía.de.los.Angeles.; López García, Aída.Inés.; Paz Martínez, D.; Galindo García, Jé.Arturo.; Cuevas Acuña, Mía.Tula.; Papaqui Tapia, S.; Arana Muñoz, O.; Pérez Fernández, Mía.Susana. 2006: Prevalence of seropositividad to antibodies IgG and IgM against Helicobacter pylori in the medical residents of the University Hospital of Puebla Revista Alergia Mexico 53(2): 69-72
Gościniak, G.; Przondo-Mordarska, A.; Iwańczak, B.; Poniewierka, E. 2000: Neutralisation of vacuolating activity of cytotoxin by serum antibodies of Helicobacter pylori infected patients Acta Microbiologica Polonica 49(2): 113-120
Murakami, K.; Kamada, T.; Ishikawa, H.; Imamura, H.; Matsumoto, H.; Fujita, M.; Ken-Tarumi, I.; Shiotani, A.; Mizukami, K.; Shiota, S.; Okimoto, T.; Kodama, M.; Akiyoshi, A.; Atsunari, T.Noda, O.; Hata, J.; Haruma, K.; Fujioka, T. 2011: An Evaluation of the Performance of a Novel Stick-Type Kit for Rapid Detection of Helicobacter Pylori Antibodies in Urine Clinical Laboratory 57(7-8): 481-487
Mincis, M. 1991: Anti-Helicobacter pylori drugs must be considered as first line therapy in peptic ulcer Amb: Revista da Associacao Medica Brasileira 37(1): 51-52